These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20363968)

  • 1. Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes.
    Nikoopour E; Schwartz JA; Huszarik K; Sandrock C; Krougly O; Lee-Chan E; Singh B
    J Immunol; 2010 May; 184(9):4779-88. PubMed ID: 20363968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.
    Qin HY; Sadelain MW; Hitchon C; Lauzon J; Singh B
    J Immunol; 1993 Mar; 150(5):2072-80. PubMed ID: 8436836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant treatment suppresses IL-17 production by T cell-independent myeloid sources in nonobese diabetic mice.
    Gao X; Ding G; Wang Z; Fu H; Ni Z; Ma J; Song S; Liu F; Fu Z
    Mol Immunol; 2010 Aug; 47(14):2397-404. PubMed ID: 20554001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development.
    Mori Y; Kodaka T; Kato T; Kanagawa EM; Kanagawa O
    Int Immunol; 2009 Nov; 21(11):1291-9. PubMed ID: 19778991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes.
    Lee IF; Qin H; Priatel JJ; Tan R
    Eur J Immunol; 2008 Jan; 38(1):82-9. PubMed ID: 18085661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R; Melican NS; Weiner HL
    J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
    Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
    J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
    Qu P; Ji RC; Shimoda H; Miura M; Kato S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
    J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
    Qin HY; Chaturvedi P; Singh B
    Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephalitogenicity of complete Freund's adjuvant relative to CpG is linked to induction of Th17 cells.
    Tigno-Aranjuez JT; Jaini R; Tuohy VK; Lehmann PV; Tary-Lehmann M
    J Immunol; 2009 Nov; 183(9):5654-61. PubMed ID: 19812193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant effect of IL-12: conversion of peptide antigen administration from tolerizing to immunizing for CD8+ T cells in vivo.
    Schmidt CS; Mescher MF
    J Immunol; 1999 Sep; 163(5):2561-7. PubMed ID: 10452994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complete Freund's adjuvant-induced splenic T cell apoptosis in the prevention of diabetes in non-obese diabetic mice].
    Wang XX; Niu XH; Zhou ZG
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):105-7. PubMed ID: 12575330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human LT-alpha-mediated resistance to autoimmune diabetes is induced in NOD, but not NOD-scid, mice and abrogated by IL-12.
    Miyaguchi S; Satoh J; Takahashi K; Sakata Y; Nakazawa T; Miyazaki J; Toyota T
    Clin Immunol; 2001 Jan; 98(1):119-24. PubMed ID: 11141334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation.
    Serreze DV; Chapman HD; Post CM; Johnson EA; Suarez-Pinzon WL; Rabinovitch A
    J Immunol; 2001 Jan; 166(2):1352-9. PubMed ID: 11145720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.
    Herbelin A; Gombert JM; Lepault F; Bach JF; Chatenoud L
    J Immunol; 1998 Sep; 161(5):2620-8. PubMed ID: 9725264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.
    Moritani M; Yoshimoto K; Ii S; Kondo M; Iwahana H; Yamaoka T; Sano T; Nakano N; Kikutani H; Itakura M
    J Clin Invest; 1996 Oct; 98(8):1851-9. PubMed ID: 8878437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.